J.B. Chemicals & Pharmaceuticals Lt (Delisted) share news and announcements

BSE: 506943Pharmaceuticals & Biotechnology

Last traded ₹2,408.90 on 16 Jul 2026

Delisted on 12 Oct 2026.

J.B. Chemicals & Pharmaceuticals Lt share news and announcements

1,922 announcements, routine notices left out, newest first. Page 4 of 39.

Sep 2025
- 8 Sep · General Updates
  Disclosure under Regulation 30 of the SEBI (Listing obligations and Disclosure Requirements), Regulations, 2015 (opens in a new tab)
- 4 Sep · Corrigendum
  Corrigendum to the public announcement, detailed public statement and the draft letter of offer for the attention of the eligible shareholders of the company. (opens in a new tab)
- 4 Sep · Updates on Open Offer
  Corrigendum to the Public Announcement, Detailed Public Statement and the Draft Letter of Offer for .... (opens in a new tab)
- 1 Sep · Disclosure
  Allotment of 140236 Shares. (opens in a new tab)
- 1 Sep · Disclosure
  Allotment of equity shares on exercise of stock options pursuant to employee stock option scheme (opens in a new tab)
Aug 2025
- 31 Aug · Management
  Cessation of Non-Executive Independent Director upon completion of term (opens in a new tab)
- 31 Aug · Management
  Cessation of Ms Padmini Khare Kaicker as Non- Executive Independent Director of the company w.e.f. August 30, 2025. (opens in a new tab)
- 14 Aug · Disclosure
  Allotment of Equity Shares on exercise of Stock Options pursuant to Employee Stock Option Scheme (opens in a new tab)
- 14 Aug · Disclosure
  Allotment of 114999 Shares. (opens in a new tab)
- 11 Aug · Disclosure
  Allotment of Equity shares on exercise of Stock Options pursuant to Employee Stock Option Scheme (opens in a new tab)
- 11 Aug · Disclosure
  Allotment of 23003 Shares. (opens in a new tab)
- 6 Aug · Meeting
  Result of Voting at Annual General Meeting alongwith Scrutinizer's Report on Voting (opens in a new tab)
- 6 Aug · Meeting
  Copy Srutinizers report of Annual General Meeting held on August 06, 2025. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
- 6 Aug · Management
  Change in Auditors of the company. (opens in a new tab)
- 6 Aug · General Updates
  Change in Registered Office (opens in a new tab)
- 6 Aug · Management
  Change in Auditors of the company. (opens in a new tab)
- 6 Aug · Management
  Appointment of Mr Nikhil Chopra as Executive Director of the company w.e.f. October 05, 2025. (opens in a new tab)
- 6 Aug · Management
  Appointment of Mr Sumit Bose as Independent Director of the company w.e.f. August 31, 2025. (opens in a new tab)
- 6 Aug · Management
  Appointment of Mr Ashwani Kumar Puri as Independent Director of the company w.e.f. May 14, 2025. (opens in a new tab)
- 6 Aug · Management
  Appointment of Ms Richa Arora as Independent Director of the company w.e.f. July 10, 2025. (opens in a new tab)
- 6 Aug · Meeting
  Proceedings of Annual General Meeting held on August 06, 2025 (opens in a new tab)
- 6 Aug · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
  Change in Registered office of the Company (opens in a new tab)
- 6 Aug · Management
  Appointment of Secretarial Auditors (opens in a new tab)
- 6 Aug · Management
  Re-appointment of Statutory Auditors (opens in a new tab)
- 6 Aug · Management
  Re-appointment of Mr. Nikhil Chopra as CEO and Whole-time Director (opens in a new tab)
- 6 Aug · Management
  Re-appointment of Mr. Sumit Bose as Non-Executive Independent Director of the Company (opens in a new tab)
- 6 Aug · Management
  Appointment of Ms. Richa Arora as Non-Executive Independent Director of the Company (opens in a new tab)
- 6 Aug · Management
  Appointment of Mr. Ashwani Kumar Puri as Non-Executive Independent Director of the Company (opens in a new tab)
- 6 Aug · Meeting
  Proceedings of the Annual General Meeting (opens in a new tab)
Jul 2025
- 30 Jul · Business
  Press release dated July 30, 2025, titled "Press Release". (opens in a new tab)
- 30 Jul · Results
  Financial results for the period ended Jun 30, 2025. (opens in a new tab)
- 30 Jul · Business
  Press Release (opens in a new tab)
- 30 Jul · Board meeting
  Unaudited standalone and consolidated financial results for the quarter ended on June 30, 2025 accompanied by limited review report. (opens in a new tab)
- 23 Jul · Analysts
  Schedule of meet (opens in a new tab)
- 23 Jul · Analysts
  Investors/analysts call with Management (opens in a new tab)
- 22 Jul · Business
  Allotment of 259077 securities pursuant to ESOP/ESPS at its meeting held on July 22, 2025 (opens in a new tab)
- 22 Jul · Disclosure
  Allotment of equity shares on exercise of stock options pursuant to Employee Stock Option Scheme (opens in a new tab)
- 21 Jul · Board meeting
  To consider and approve the unaudited financial results for the period ended Jun 30, 2025 (opens in a new tab)
- 21 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve the unaudited .... (opens in a new tab)
- 17 Jul · Letter To Shareholders - Integrated Annual Report
  Letter to shareholders - Integrated Annual Report 2024-25 (opens in a new tab)
- 17 Jul · Updates
  Letter To Shareholders - Integrated Annual Report FY 2024-25 (opens in a new tab)
- 12 Jul · Draft Letter of Offer
  Draft Letter of Offer to the Public Shareholders of JB Chemicals & Pharmaceuticals Ltd ("Target Company"). (opens in a new tab)
- 11 Jul · Business Responsibility and Sustainability Reporting (BRSR)
  BRSR (opens in a new tab)
- 11 Jul · Corporate action
  Intimation of Record date (opens in a new tab)
- 11 Jul · Corporate action
  Record date for the purpose of Final Dividend 2024-25 is 30-Jul-2025. (opens in a new tab)
- 11 Jul · Meeting
  Notice of Annual General Meeting to be held on August 06, 2025 (opens in a new tab)
- 11 Jul · Meeting
  Notice of Annual General Meeting to be held on August 6, 2025 at 1:30 pm. (opens in a new tab)
- 10 Jul · Management
  Appointment of Ms Richa Arora as Non- Executive Independent Director of the company w.e.f. July 10, 2025. (opens in a new tab)
- 10 Jul · Management
  Change in Director - Appointment of Non-Executive Independent Director (opens in a new tab)
- 4 Jul · Public Announcement-Open Offer
  Detailed public statement in terms of Regulations 3(1) and 4 Read with Regulations 13(4), 14 (3) and 15(2) and other applicable regulations of the securities and Exchange Board of India (SAST) Regulations, 2011 , as amended, to the eligible shareholders ( as defined below) of the company. (opens in a new tab)